Xenon Pharmaceuticals Inc. Share Price
XENEXenon Pharmaceuticals Inc. Stock Performance
Open $60.45 | Prev. Close $60.38 | Circuit Range N/A |
Day Range $59.63 - $60.76 | Year Range $30.03 - $63.50 | Volume 73,614 |
Average Traded $60.19 |
Xenon Pharmaceuticals Inc. Share Price Chart
About Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc., a neuroscience-focused biopharmaceutical company, engages in the discovery, development, and delivery of therapeutics to treat patients with neurological and psychiatric disorders in Canada. Its product candidates include Azetukalner, a selective Kv7 potassium channel opener in Phase 3 clinical development for the treatment of epilepsy, including focal onset seizures, and primary generalized tonic-clonic seizures, as well as neuropsychiatric disorders, such as major depressive disorder and bipolar depression. The company has a license and collaboration agreement with the Neurocrine Biosciences, Inc. for the development of NBI-921352, a Nav1.2/1.6 sodium channel inhibitor that is in Phase 1 clinical trials for the treatment of certain types of epilepsy. Xenon Pharmaceuticals Inc. was incorporated in 1996 and is headquartered in Burnaby, Canada.
Xenon Pharmaceuticals Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
30-Jun-26 | $60.10 | $60.36 | +0.37% |
29-Jun-26 | $59.36 | $60.14 | +0.69% |
26-Jun-26 | $57.23 | $59.73 | +5.24% |
25-Jun-26 | $55.70 | $56.76 | +2.09% |
24-Jun-26 | $55.23 | $55.59 | +1.82% |
23-Jun-26 | $55.16 | $54.60 | -0.36% |
22-Jun-26 | $53.33 | $54.80 | +3.66% |